News

Digital Europe Main Work Programme 2025-2027 published

Published on | 3 months ago

Programmes Digital Europe AI Continent Advanced Digital Skills Deployment: Best use of technologies

The European Commission has published today the Digital Europe Main Work Programme 2025-2027, detailing the plans for remaining 3 years of the current programme period.

The main work programme focuses on the Specific Objectives AI, data & cloud, Advanced Digital Skills and Deployment-Accelerating the best use of technologies.

The work programme can be found on the dedicated website of the European Commission.

NCP Flanders organises an info session on the upcoming calls on 14 April 2025.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1641 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.